<unk>  is an antimalarial drug for uncomplicated malaria caused by P. falciparum (and chloroquine-resistant P. falciparum) or chloroquine-resistant P. vivax parasites.<unk>  can also be used to treat severe malaria. The World Health Organization (WHO) recommends the treatment of uncomplicated P. falciparum with<unk> emisinin-based combination therapy. Given in combination with lumefantrine, it may be followed by a 14-day regimen of primaquine to prevent relapse of P. vivax or P. ovale malarial parasites and provide a complete cure.<unk>  can also be used in treating and preventing trematode infections of schistosomiasis when used in combination with praziquantel.<unk>  is rated category C by the FDA based on animal studies where<unk> emisinin derivatives have shown an association with fetal loss and deformity. Some studies, however, do not show evidence of harm.
Artemether
Delamanid
Primaquine
Quinine
Piperaquine
Mefloquine
Tafenoquine
Proguanil